Nordic implementation of personalised prostate cancer diagnostics

Important results from the project

** Denna text är maskinöversatt ** Prostate cancer is the most common cancer in Sweden and in the other Nordic countries. Today´s diagnostics are inaccurate, which leads to both overdiagnosis and missed serious cancers. The NorDCaP project aim to accelerate the implementation of world-leading diagnostics for prostate cancer developed at Karolinska Institutet with the Stockholm3 blood test and magnetic camera for healthcare providers in the Nordic countries.

Expected long term effects

** Denna text är maskinöversatt ** NorDCaP´s introduction of improved diagnostics with the Stockholm3 test and magnetic camera leads to fewer unnecessary biopsies, magnetic camera examinations and treatments, earlier detection of serious prostate cancer and a lower risk of side effects. In summary, it leads to care that is better for the individual patient and to lower costs for healthcare.

Approach and implementation

** Denna text är maskinöversatt ** NorDCaP has worked in teams consisting of women and men from healthcare and industry. We have divided the work into nine work packages with deliverables for each work package. Seven of the work packages are fully completed while two work packages have been delayed due to the ongoing Corona pandemic. For these two work packages, supplementary funding been secured so that they can be completed in 2022. In addition to two physical meetings, in Stockholm and Aarhus pre Corona, respectively, communication has mainly been handled virtually.